# Nivolumab With DC Vaccines for Recurrent Brain Tumors

> **NCT02529072** · PHASE1 · COMPLETED · sponsor: **Gary Archer Ph.D.** · enrollment: 6 (actual)

## Conditions studied

- Malignant Glioma
- Astrocytoma
- Glioblastoma

## Interventions

- **DRUG:** nivolumab
- **BIOLOGICAL:** DC

## Key facts

- **NCT ID:** NCT02529072
- **Lead sponsor:** Gary Archer Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-09-15
- **Final completion:** 2019-12-30
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-03-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02529072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02529072, "Nivolumab With DC Vaccines for Recurrent Brain Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02529072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*